. 2015 Nov 24;60(2):300–312. doi: 10.1002/mnfr.201500595

Table 1.

Alleviation of obesity and improvement in the levels of blood constituents by quercetin in mice fed a Western diet

	Control diet	Western diet	Western diet+ 0.05% quercetin
Body weight (g)	35.66 ± 1.46^a	45.77 ± 0.95^b	41.69 ± 1.33^c
Liver weight (g)	1.46 ± 0.08^a	3.47 ± 0.28^b	2.13 ± 0.19^c
Kidney weight (g)	0.37 ± 0.01	0.36 ± 0.01	0.38 ± 0.01
Pancreas weight (g)	0.28 ± 0.02	0.30 ± 0.03	0.27 ± 0.02
Visceral fat (g/mouse)	2.25 ± 0.43^a	4.34 ± 0.12^b	3.33 ± 0.36^a,b
Blood glucose (mg/dL)	143 ± 5^a	224 ± 9^b	151 ± 9^a
Plasma insulin (ng/mL)	1.84 ± 0.47^a	4.88 ± 0.67^b	2.22 ± 0.32^a
Plasma cholesterol (mg/dL)	76.2 ± 10.9^a	194.0 ± 9.2^b	123.3 ± 12.4^c
Plasma leptin (ng/mL)	1.46 ± 0.61^a	5.78 ± 0.58^b	2.81 ± 0.51^a
Plasma adiponectin (μg/mL)	4.42 ± 0.42^a	2.87 ± 0.11^b	3.18 ± 0.50^a,b
Plasma resistin (ng/mL)	18.7 ± 1.2	22.2 ± 1.4	21.8 ± 1.2
Plasma TNFα (pg/mL)	13.2 ± 2.6^a	34.9 ± 3.5^b	19.9 ± 2.8^a
Plasma IFNγ (pg/mL)	2.11 ± 0.33^a	6.81 ± 1.3^b	3.21 ± 0.58^a

C57BL/6J mice were fed the control AIN93G diet or a Western diet containing either 0% or 0.05% quercetin for 18 weeks. Values are expressed as the mean ± SEM of 6–9 mice in each group. Different superscripts indicate significant differences (p < 0.05, two‐sided).